Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Pain, instability, and familial discord: a qualitative study into women who use drugs in Malaysia.

Rahman F, Lall P, Iqbal S, Vicknasingam B.

Harm Reduct J. 2015 Nov 5;12:52. doi: 10.1186/s12954-015-0086-6.

2.

Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago.

Echevarria D, Gutfraind A, Boodram B, Major M, Del Valle S, Cotler SJ, Dahari H.

PLoS One. 2015 Aug 21;10(8):e0135901. doi: 10.1371/journal.pone.0135901. eCollection 2015.

3.

High rates of abscesses and chronic wounds in community-recruited injection drug users and associated risk factors.

Smith ME, Robinowitz N, Chaulk P, Johnson KE.

J Addict Med. 2015 Mar-Apr;9(2):87-93. doi: 10.1097/ADM.0000000000000093.

4.

Control over drug acquisition, preparation and injection: Implications for HIV and HCV risk among young female injection drug users.

Wagner KD, Bloom JJ, Hathazi SD, Sanders B, Lankenau SE.

ISRN Addict. 2013 May 12;2013. pii: 289012.

5.

Refining HIV risk: the modifying effects of youth, gender and education among people who inject drugs in Poland.

Czerwinski M, McNutt LA, DeHovitz JA, Zielinski A, Rosinska M.

PLoS One. 2013 Jul 23;8(7):e68018. doi: 10.1371/journal.pone.0068018. Print 2013.

6.

Analysis of duration of risk behaviour for key populations: a literature review.

Fazito E, Cuchi P, Mahy M, Brown T.

Sex Transm Infect. 2012 Dec;88 Suppl 2:i24-32. doi: 10.1136/sextrans-2012-050647. Review.

7.

Barriers to drug treatment for IDU couples: the need for couple-based approaches.

Simmons J, McMahon JM.

J Addict Dis. 2012;31(3):242-57. doi: 10.1080/10550887.2012.702985.

8.

Retrospective accounts of injection initiation in intimate partnerships.

Simmons J, Rajan S, McMahon JM.

Int J Drug Policy. 2012 Jul;23(4):303-11. doi: 10.1016/j.drugpo.2012.01.009. Epub 2012 Mar 6.

9.

Access to housing subsidies, housing status, drug use and HIV risk among low-income U.S. urban residents.

Dickson-Gomez J, McAuliffe T, Convey M, Weeks M, Owczarzak J.

Subst Abuse Treat Prev Policy. 2011 Nov 23;6:31. doi: 10.1186/1747-597X-6-31.

10.

Basic subsistence needs and overall health among human immunodeficiency virus-infected homeless and unstably housed women.

Riley ED, Moore K, Sorensen JL, Tulsky JP, Bangsberg DR, Neilands TB.

Am J Epidemiol. 2011 Sep 1;174(5):515-22. doi: 10.1093/aje/kwr209. Epub 2011 Jul 11.

11.

Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.

Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K.

Addiction. 2010 Jul;105(7):1254-64. doi: 10.1111/j.1360-0443.2010.02949.x. Epub 2010 May 14.

12.

Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study.

Pollini RA, Lozada R, Gallardo M, Rosen P, Vera A, Macias A, Palinkas LA, Strathdee SA.

AIDS Behav. 2010 Jun;14(3):679-87. doi: 10.1007/s10461-010-9674-3.

13.

Needle and syringe sharing among Iranian drug injectors.

Rafiey H, Narenjiha H, Shirinbayan P, Noori R, Javadipour M, Roshanpajouh M, Samiei M, Assari S.

Harm Reduct J. 2009 Jul 30;6:21. doi: 10.1186/1477-7517-6-21.

14.

The relationship between housing status and HIV risk among active drug users: a qualitative analysis.

Dickson-Gomez J, Hilario H, Convey M, Corbett AM, Weeks M, Martinez M.

Subst Use Misuse. 2009;44(2):139-62. doi: 10.1080/10826080802344823.

15.

HIV risk behaviors among female IDUs in developing and transitional countries.

Cleland CM, Des Jarlais DC, Perlis TE, Stimson G, Poznyak V; WHO Phase II Drug Injection Collaborative Study Group.

BMC Public Health. 2007 Oct 1;7:271.

Supplemental Content

Support Center